Bisphenol A and peripheral arterial disease: Results from the NHANES

Environmental Health Perspectives

Volumn 120, Issue 9, 2012, Pages 1297-1300

  Shankar, Anoop ^a   Teppala, Srinivas ^a   Sabanayagam, Charumathi ^a,b,c  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Ankle brachial index; Bisphenol A; CVD; NHANES; Peripheral arterial disease

Indexed keywords

4, 4' ISOPROPYLIDENEDIPHENOL; UNCLASSIFIED DRUG;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MASS FRAGMENTOGRAPHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE;

ANIMALIA;

ADULT; ANKLE BRACHIAL INDEX; BENZHYDRYL COMPOUNDS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PHENOLS; RISK FACTORS; UNITED STATES;

EID: 84930480035     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104114     Document Type: Article

References (35)

1. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. 2006. The estrogenic effect of bisphenol A disrupts pancreatic b-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106-112.
2. American Diabetes Association. 2003. Peripheral arterial disease in people with diabetes. Diabetes Care 26:3333-3341.
3. American Diabetes Association. 2011. Diagnosis and classification of diabetes mellitus. Diabetes Care 34(suppl 1:S62-S69.
4. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. 2005. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391-395.
5. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. 2008. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116:39-44.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206-1252.
7. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. 1992. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381-386.
8. Hennig B, Hammock BD, Slim R, Toborek M, Saraswathi V, Robertson LW. 2002. PCB-induced oxidative stress in endothelial cells: modulation by nutrients. Int J Hyg Environ Health 205:95-102.
9. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. 2006. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation 113:e463-e654; doi: 10.1161/CIRCULATIONAHA.106.174526.
10. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, et al. 2008. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303-1310.
11. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. 2006. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247-254.
12. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, Priymenko N, et al. 2012. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55:395-407.
13. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. 2005. Bisphenol A accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 84:319-327.
14. Matsushima A, Teramoto T, Okada H, Liu X, Tokunaga T, Kakuta Y, et al. 2008. ERRg tethers strongly bisphenol A and 4-a-cumylphenol in an induced-fit manner. Biochem Biophys Res Commun 373:408-413.
15. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. 2010. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS One 5:e8673; doi:10.1371/journal.pone.0008673 [Online 13 January 2010].
16. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, et al. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185-5190.
17. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PW. 2003. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med 163:1939-1942.
18. National Kidney Foundation. 2002. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S266.
19. NCHS (National Center for Health Statistics). 2010a. 2003-2004 National Health and Nutrition Examination Survey: 2003-2004 Data Documentation, Codebook, and Frequencies-Lower Extremity Disease-Ankle Brachial Blood Pressure Index (LEXAB_C). Available: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/LEXAB_C.htm [accessed 4 May 2011].
20. NCHS (National Center for Health Statistics). 2010b. 2003-2004 National Health and Nutrition Examination Survey: Survey Operations Manuals, Brochures, Consent Documents. Available: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/current_nhanes_03_04.htm [accessed 22 April 2011].
21. NCHS (National Center for Health Statistics). 2010c. Laboratory Procedure Manual for Serum Creatinine. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l40_c_met_creatinine.pdf [accessed 26 September 2011].
22. NCHS (National Center for Health Statistics). 2010d. NHANES 2003-2004 Data Release: January 2006. General Information about the NHANES 2003-2004 Laboratory Methodology and Public Data Files. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/lab_c_generaldoc.pdf [accessed 22 April 2011].
23. Newbold RR, Padilla-Banks E, Jefferson WN. 2009. Environmental estrogens and obesity. Mol Cell Endocrinol 304:84-89.
24. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. for the Cardiovascular Heart Study (CHS) Collaborative Research Group. 1993. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 88:837-845.
25. Ooe H, Taira T, Iguchi-Ariga SM, Ariga H. 2005. Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol Sci 88:114-126.
26. Phrakonkham P, Viengchareun S, Belloir C, Lombes M, Artur Y, Canivenc-Lavier MC. 2008. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol 110:95-103.
27. Ropero AB, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A. 2008. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31:194-200.
28. Rubin BS, Soto AM. 2009. Bisphenol A: Perinatal exposure and body weight. Mol Cell Endocrinol 304:55-62.
29. Selvin E, Erlinger TP. 2004. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110:738-743.
30. Selvin E, Manzi J, Stevens LA, Van LF, Lacher DA, Levey AS, et al. 2007. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 50:918-926.
31. Stegeman JJ, Hahn ME, Weisbrod R, Woodin BR, Joy JS, Najibi S, et al. 1995. Induction of cytochrome P4501A1 by aryl hydrocarbon receptor agonists in porcine aorta endothelial cells in culture and cytochrome P4501A1 activity in intact cells. Mol Pharmacol 47:296-306.
32. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. 2009. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30:75-95.
33. World Health Organization/Food and Agriculture Organization of the United Nations Expert Panel. 2011. Toxicological and Health Aspects of Bisphenol A. Available at: http://whqlibdoc.who.int/publications/2011/97892141564274_eng.pdf [accessed 26 September 2011].
34. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, et al. 2000. A synthetic antagonist for the peroxisome proliferator-activated receptor g inhibits adipocyte differentiation. J Biol Chem 275:1873-1877.
35. Ye X, Kuklenyik Z, Needham LL, Calafat AM. 2005. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407-5413.